- There were around 4,600 stomach cancer deaths in the UK in 2014, that’s 13 deaths every day.
- Stomach cancer is the 12th most common cause of cancer death in the UK (2014).
- Stomach cancer accounts for 3% of all cancer deaths in the UK (2014).
- In males in the UK, stomach cancer is the eighth most common cause of cancer death, with around 2,900 deaths in 2014.
- In females in the UK, stomach cancer is the 13th most common cause of cancer death, with around 1,700 deaths in 2014.
- Around 6 in 10 (59%) stomach cancer deaths in the UK each year are in people aged 75 and over (2012-2014).
- Mortality rates for stomach cancer in the UK are highest in people aged 90+ (2012-2014).
- Stomach cancer mortality rates in the UK have fallen by more than three-quarters over the last 40 years.
- Stomach cancer deaths in England are more common in people living in the most deprived areas.
- In Europe, more than 107,000 people were estimated to have died from stomach cancer in 2012. The UK mortality rate is seventh lowest in Europe for males and fourth lowest for females.
- Worldwide, around 723,000 people were estimated to have died from stomach cancer in 2012, with mortality rates varying across the world.
Stomach cancer statistics
New cases of stomach cancer, 2013, UK
Deaths from stomach cancer, 2014, UK
Survive stomach cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of stomach cancer, UK
- There were around 7,100 new cases of stomach cancer in the UK in 2013, that’s 19 cases diagnosed every day.
- Stomach cancer is the 16th most common cancer in the UK (2013).
- Stomach cancer accounts for 2% of all new cases in the UK (2013).
- In males in the UK, stomach cancer is the 13th most common cancer, with around 4,600 cases diagnosed in 2013.
- In females in the UK, stomach cancer is the 15th most common cancer, with around 2,500 cases diagnosed in 2013.
- Around half (51%) of stomach cancer cases in the UK each year are diagnosed in people aged 75 and over (2011-2013).
- Since the late 1970s, stomach cancer incidence rates have decreased by more than three-fifths (62%) in Great Britain. The increase is similar in males (62%, around three-fifths) and females (66%, two-thirds).
- Over the last decade, stomach cancer incidence rates have decreased by more than a quarter (27%) in the UK, with similar decreases in males (29%) and females (27%).
- 1 in 67 men and 1 in 135 women will be diagnosed with stomach cancer during their lifetime.
- Most stomach cancers occur in the cardia.
- In Europe, more than 139,000 new cases of stomach cancer were estimated to have been diagnosed in 2012. The UK incidence rate is fifth lowest in Europe for males and fourth lowest for females.
- Worldwide, more than 951,000 people were diagnosed with stomach cancer in 2012, with incidence rates varying across the world.
- Stomach cancer in England is more common in people living in the most deprived areas.
- Stomach cancer is most common in Black people, then White people, and least common in Asian people.
- In the UK around 13,400 people were still alive at the end of 2006, up to ten years after being diagnosed with stomach cancer.
- 3 in 20 (15%) people diagnosed with stomach cancer in England and Wales survive their disease for ten years or more (2010-11).
- Around a fifth (19%) of people diagnosed with stomach cancer in England and Wales survive their disease for five years or more (2010-11).
- More than 4 in 10 (42%) of people diagnosed with stomach cancer in England and Wales survive their disease for one year or more (2010-11).
- Stomach cancer survival is higher in men than women at one-year, but similar at five- and ten-years.
- Around a third of people in England diagnosed with stomach cancer aged 15-39 survive their disease for five years or more, compared with around a tenth of people diagnosed aged 80 and over (2009-2013).
- Stomach cancer survival is improving and has almost tripled in the last 40 years in the UK.
- In the 1970s, around 5 in 100 people diagnosed with stomach cancer survived their disease beyond ten years, now it's 3 in 20.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 75% (78% in males and 69% in females) of stomach cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- H. Pylori infection is the main potentially avoidable risk factor for stomach cancer, linked to an estimated 32% of stomach cancer cases in the UK.
- An estimated 75% of stomach cancers in the UK are linked to lifestyle factors including H. pylori infection, consuming too much salt (24%), and smoking (22%).
- Ionising radiation and certain occupational exposures cause stomach cancer.
- A diet high in fruit and vegetables may protect against stomach cancer – insufficient fruit and vegetables intake is linked to an estimated 36% of stomach cancer cases in the UK.
- Alcohol, certain medical conditions, and overweight and obesity may relate to higher stomach cancer risk, but evidence is unclear.
- 'Emergency presentation' is the most common route to diagnosing stomach cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.
- More than 3 in 20 stomach cancer patients receive major surgical resection as part of their cancer treatment.
- Almost 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- 9 in 10 of patients are given the name of their Clinical Nurse Specialist.
The latest statistics available for stomach cancer in the UK are; incidence 2013, mortality 2014 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Generally, the studies cited in our risk factors section are on stomach
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Stomach cancer is part in the group 'Upper Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: oesophagus, stomach, liver, gallbladder, other and unspecified parts of biliary tract, pancreas, secondary cancers of liver, intrahepatic bile duct and duodenum.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.